Chinese heart valve maker Venus Medtech announced the acquisition of InterValve, a US-based company whose V8 and TAV8 aortic valvuloplasty balloon catheters are used in percutaneous balloon angioplasty and transcatheter aortic valve replacement procedures. Terms of the transaction were not disclosed.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.